BiotechTube

estradiol, 10 mcg + estradiol, 25 mcg + placebo

Phase 3Completed
0 watching 0 views this week📈 Rising
76
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Menopause

Conditions

Menopause, Postmenopausal Vaginal Atrophy

Trial Timeline

Aug 31, 1994 → Nov 30, 1995

NCT ID
NCT00465192

About estradiol, 10 mcg + estradiol, 25 mcg + placebo

estradiol, 10 mcg + estradiol, 25 mcg + placebo is a phase 3 stage product being developed by Novo Nordisk for Menopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00465192. Target conditions include Menopause, Postmenopausal Vaginal Atrophy.

Hype Score Breakdown

Clinical
27
Activity
18
Company
9
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00465192Phase 3Completed

Competing Products

20 competing products in Menopause

See all competitors
ProductCompanyStageHype Score
atomoxetine + placeboEli LillyPre-clinical
23
Fezolinetant + PlaceboAstellas PharmaPhase 2
52
CetrorelixShionogiPre-clinical
23
Teriparatide (PTH 1-34)Eli LillyPhase 2/3
65
Eszopiclone + PlaceboSumitomo PharmaPre-clinical
23
Comparator: placebo + Comparator: EstraceMerckPhase 1
33
esmirtazapine + PlaceboMerckPhase 3
77
Marketed low dose hormone replacement therapyNovo NordiskPre-clinical
22
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)Novo NordiskPre-clinical
22
1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)Novo NordiskApproved
84
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)Novo NordiskPhase 1
32
estradiol, 25 mcgNovo NordiskPre-clinical
22
estradiol, 10 mcgNovo NordiskPhase 3
76
estradiol, 10 mcg + estradiol, 25 mcgNovo NordiskPhase 1
32
estradiol, 10 mcgNovo NordiskPhase 3
76
2 mg estradiol / 1 mg norethisterone acetate (NETA)Novo NordiskPhase 1
32
estradiol, 25 mcgNovo NordiskPhase 3
76
estradiol, 25 mcgNovo NordiskPhase 3
76
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + placeboNovo NordiskPhase 3
76
estradiol, 25 mcg + estradiol, 25 mcgNovo NordiskPhase 1
32

Other Products from Novo Nordisk

Liraglutide 3.0mg + Placebo Oral Tablet + Phentermine 15 MGApproved
84
Liraglutide + SalineApproved
84
Hydrocortisone + PlaceboApproved
84
biphasic insulin aspart + insulin aspartApproved
84
Semaglutide, 1.34 mg/mL + Empagliflozin 25 MGApproved
84